Peptide record

TPDB06382

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06382
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept APD_complete HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 11-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KKLLKWLKKLL
Physicochemical Analysis
C71H127N17O12
ARNDCEQGHIMFPSTYV
LK
1410.90
11.12
5
0
6
+5
0.30
-0.127
177.27
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
5500
389.82
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
5
L
5
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 5 K: 5 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
11
C71H127N17O12
1410.90
11.12
+5
0.30
-0.127
Evidence Records 40 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

B. subtilis ATCC 6633

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus
Evidence 2 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

Staphylococcus aureus ATCC 6538p

Source & Reference

dbAMP DRAMP

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. c
Evidence 3 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

S.epidermis ATCC 12228

Source & Reference

dbAMP DRAMP

Other

gainst Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dyse
Evidence 4 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

M. luteus ATCC 10240

Source & Reference

dbAMP DRAMP

Other

6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S.
Evidence 5 Activity

Activity

MIC
Antibacterial
12.5 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP

Other

/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. p
Evidence 6 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

S. dysentariae ATCC 9752

Source & Reference

dbAMP DRAMP

Other

ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and
Evidence 7 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

S. typhimorium ATCC 14028

Source & Reference

dbAMP DRAMP

Other

ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 8 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

Klebsiella pneumoniae ATCC 10031

Source & Reference

dbAMP DRAMP

Other

/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 9 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP DRAMP

Other

, S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 10 Activity

Activity

MIC
Antifungal
6.3 µg/mL

Target

B. subtilis ATCC 6633

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus
Evidence 11 Activity

Activity

MIC
Antifungal
6.3 µg/mL

Target

Staphylococcus aureus ATCC 6538p

Source & Reference

dbAMP DRAMP Antifungipept

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. c
Evidence 12 Activity

Activity

MIC
Antifungal
6.3 µg/mL

Target

S.epidermis ATCC 12228

Source & Reference

dbAMP DRAMP Antifungipept

Other

gainst Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dyse
Evidence 13 Activity

Activity

MIC
Antifungal
6.3 µg/mL

Target

M. luteus ATCC 10240

Source & Reference

dbAMP DRAMP Antifungipept

Other

6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S.
Evidence 14 Activity

Activity

MIC
Antifungal
12.5 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP Antifungipept

Other

/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. p
Evidence 15 Activity

Activity

MIC
Antifungal
6.3 µg/mL

Target

S. dysentariae ATCC 9752

Source & Reference

dbAMP DRAMP Antifungipept

Other

ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and
Evidence 16 Activity

Activity

MIC
Antifungal
25 µg/mL

Target

S. typhimorium ATCC 14028

Source & Reference

dbAMP DRAMP Antifungipept

Other

ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 17 Activity

Activity

MIC
Antifungal
6.3 µg/mL

Target

Klebsiella pneumoniae ATCC 10031

Source & Reference

dbAMP DRAMP Antifungipept

Other

/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 18 Activity

Activity

MIC
Antifungal
25 µg/mL

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP DRAMP Antifungipept

Other

, S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 19 Activity

Activity

MIC
Antiparasitic
6.3 µg/mL

Target

B. subtilis ATCC 6633

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus
Evidence 20 Activity

Activity

MIC
Antiparasitic
6.3 µg/mL

Target

Staphylococcus aureus ATCC 6538p

Source & Reference

DRAMP

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. c
Evidence 21 Activity

Activity

MIC
Antiparasitic
6.3 µg/mL

Target

S.epidermis ATCC 12228

Source & Reference

DRAMP

Other

gainst Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dyse
Evidence 22 Activity

Activity

MIC
Antiparasitic
6.3 µg/mL

Target

M. luteus ATCC 10240

Source & Reference

DRAMP

Other

6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S.
Evidence 23 Activity

Activity

MIC
Antiparasitic
12.5 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

DRAMP

Other

/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. p
Evidence 24 Activity

Activity

MIC
Antiparasitic
6.3 µg/mL

Target

S. dysentariae ATCC 9752

Source & Reference

DRAMP

Other

ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and
Evidence 25 Activity

Activity

MIC
Antiparasitic
25 µg/mL

Target

S. typhimorium ATCC 14028

Source & Reference

DRAMP

Other

ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 26 Activity

Activity

MIC
Antiparasitic
6.3 µg/mL

Target

Klebsiella pneumoniae ATCC 10031

Source & Reference

DRAMP

Other

/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 27 Activity

Activity

MIC
Antiparasitic
25 µg/mL

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

DRAMP

Other

, S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 28 Activity

Activity

MIC
Antiviral
6.3 µg/mL

Target

B. subtilis ATCC 6633

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus
Evidence 29 Activity

Activity

MIC
Antiviral
6.3 µg/mL

Target

Staphylococcus aureus ATCC 6538p

Source & Reference

DRAMP

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. c
Evidence 30 Activity

Activity

MIC
Antiviral
6.3 µg/mL

Target

S.epidermis ATCC 12228

Source & Reference

DRAMP

Other

gainst Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dyse
Evidence 31 Activity

Activity

MIC
Antiviral
6.3 µg/mL

Target

M. luteus ATCC 10240

Source & Reference

DRAMP

Other

6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S.
Evidence 32 Activity

Activity

MIC
Antiviral
12.5 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

DRAMP

Other

/ml), S.epidermis ATCC 12228 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. p
Evidence 33 Activity

Activity

MIC
Antiviral
6.3 µg/mL

Target

S. dysentariae ATCC 9752

Source & Reference

DRAMP

Other

ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and
Evidence 34 Activity

Activity

MIC
Antiviral
25 µg/mL

Target

S. typhimorium ATCC 14028

Source & Reference

DRAMP

Other

ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 35 Activity

Activity

MIC
Antiviral
6.3 µg/mL

Target

Klebsiella pneumoniae ATCC 10031

Source & Reference

DRAMP

Other

/ml), S. dysentariae ATCC 9752 (MIC 6.3 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 36 Activity

Activity

MIC
Antiviral
25 µg/mL

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

DRAMP

Other

, S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumoniae ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853 (MIC 25 ug/ml).
Evidence 37 Activity

Activity

7% Hemolysis
Toxicity
200 µg/mL
Hemolytic Cytotoxic
7% Hemolysis | 200 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. | J Pept Sci | 2009
Evidence 38 Activity

Activity

6% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
6% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. | J Pept Sci | 2009
Evidence 39 Activity

Activity

5% Hemolysis
Toxicity
32-6.3 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | 32-6.3 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evidence 40 Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.